Antidepressant composition
AssigneeAktiebolaget Leo
InventorsEdgar Eriksoo, Korfitz Bengt-Ingvar Ohlsson
Life of this patent
Estimating the term…
Abstract
This invention relates to novel solid compositions, e.g., tablets, pills, dispersible powders, granules, or capsules, containing as active ingredient the compound 4'-chloro-2-{[3-(10,11-dihydro-5H-dibenz(b,f)-azepinyl-(5)-propyl]-methyla mino}-acetophenone hydrochloride (in the following referred to as lofepramine hydrochloride).
Claims7
Solid antidepressant composition for oral use containing as active ingredient an orally-effective amount of lofepramine hydrochloride, at least ten percent by weight of the composition, a pharmaceutically-acceptable carrier, and a stabilizing amount, at least three percent by weight of the composition, of ascorbic acid.
Dependencies are inferred from the claim text.